Aamal : Expends Its Product Offering Through Ebn Sina Medical

08/01/2018

Aamal Company Expends its Product Offering Through Ebn Sina Medical

New agreement to import pharmaceutical products from Turkey

Doha, Qatar - 7 January 2018: Aamal Company Q.P.S.C., one of the region's fastest growing diversified companies -and its fully owned subsidiary, Ebn Sina Medical - announced today distribution agreement with Turkish Company CinnaGen Ilaç, an established firm which started operating in Turkey in 2016. The deal involves importing several biotech drugs to Qatar used for medical treatment of multiple sclerosis, rheumatoid arthritis, cancer, and blood diseases.

The signing ceremony took place in Doha, with the attendance of Turkey's ambassador to Qatar H.E. Mr. Fikret Özer, and CEO of CinnaGen Ilaç' Dr. Ferhat Farsi and General Manager of Ebn Sina Medical, Mr. Sherif Shehata.

Sheikh Mohamed Bin Faisal Al Thani - Vice Chairman and Managing Director of Aamal Company Q.P.S.C. - commented: 'We are very pleased to announce this agreement with CinnaGen Ilaç, which reflects Aamal's persistence on exploring new international markets and creating cooperative relationships with companies that go in line with the quality standards of Aamal has set for its products. We are positive that this deal will support Ebn Sina organic growth, which include being alert to the market demands and adopt a proactive approach partnering with leading institutions to provide the local market with the best and latest pharmaceutical products to meet the increasing market needs'.

Mr. Sherif Shehata, General Manager of Ebn Sina Medical added: 'I'm pleased to announce this partnership with a leading pharmaceutical firm such as CinnaGen Ilaç. As we reveal this agreement, we express our determination and commitment to secure medicine availability in Qatar - based on the recommendations of the Ministry of Health - from different resources, including Turkey, which has shown strong support to the Qatari market in the status quo. Our deal with CinnaGen Ilaç came after careful search for a well-establish partner in Turkey to provide us with such an excellent opportunity to expand our product offering'.

-ends-

Further enquiries

Aamal Company	+ 974 4422 3888
Arwa Goussous, Corporate Communications Manager (mobile # [phone], Ext. 2232) Laura Ackel, Communications and Marketing Officer (mobile # [phone]) Arwa Hamdieh, IR & Compliance Manager (T) [phone]	[e-mail] [e-mail] [e-mail]

About Aamal Company Q.P.S.C.

Aamal is one of the GCC's fastest growing diversified conglomerates and has been listed on the Qatar Stock Exchange since December 2007. As at 4 January 2018, the Company had a market capitalization of QAR 5.54bn (US$ 1.51bn).

Focused on self-financed and profitable growth, Aamal's operations are widely diversified and comprise 24 active business units with market leading positions in the key industrial, retail, property, managed services, and medical equipment and pharmaceutical sectors, thereby offering investors a high quality and balanced exposure to Qatar's wider economic growth and development. Over the ten years to end-2016, the Company has delivered a compound annual growth rate in trading net profit (ie. before fair value gains on investment properties) of almost 19% a year, with minimal financial leverage.

For further information on Aamal Company, please refer to the corporate website:http://www.aamal.com.qa

About Ebn Sina Medical

Ebn Sina Medical is an ISO Certified subsidiary of Aamal Company and the leading pharmaceutical distribution company in Qatar having exclusive distribution agreements with several international pharmaceutical companies. It is active in the importation, distribution, promotion and retailing of pharmaceuticals, appliances and disposables in addition to consumer products. Ebn Sina Medical provides complete professional services to government departments, retail pharmacies, private clinics, industrial companies and the local market. Alongside this professional knowledge and expertise, Ebn Sina Medical conforms to all Qatar regulatory requirements and has implemented frequently updated quality management systems. Ebn Sina Medical is a registered trademark in Qatar. Aamal has a 100% interest in Ebn Sina Medical.

Back to 2018 press releases